Approval · Notice of Compliance 61 · 2004
CLIMARA: Notice of Compliance 61
Issued March 9, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 61
- Date
- March 9, 2004
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths: 2mg/pad, 5.7mg/pad; new indication: for the prevention of postmenopausal osteoporosis, 3.8mg/pad, 5.7mg/pad, 7.6mg/pad
- Therapeutic class
- Estrogen